Cargando…

The seroprevalence of SARS-CoV-2 in patients on haemodialysis

A new study reports the seroprevalence of SARS-CoV-2 antibodies among a cross-section of patients on haemodialysis and uses these data to estimate seroprevalence in the general US population. Although this study demonstrates the potential of monitoring infectious disease prevalence in dialysis popul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahalingasivam, Viyaasan, Tomlinson, Laurie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	News & Views
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682124/ https://www.ncbi.nlm.nih.gov/pubmed/33230249 http://dx.doi.org/10.1038/s41581-020-00379-y

Ejemplares similares

SARS-CoV-2 in the kidney: bystander or culprit?
por: Vijayan, Anitha, et al.
Publicado: (2020)

Potential SARS-CoV-2 kidney infection and paths to injury
por: Hassler, Luise, et al.
Publicado: (2022)

Is SARS-CoV-2-induced testicular damage in hamsters relevant?
por: Dejucq-Rainsford, Nathalie
Publicado: (2022)

SARS-CoV-2 fires up inflammation in adipose tissue
por: Stefan, Norbert
Publicado: (2022)

Halting SARS‐CoV‐2: lung organoids step up to the plate
por: Leibel, Sandra L, et al.
Publicado: (2021)

RNAi to treat SARS‐CoV‐2—variant proofing the next generation of therapies
por: McMillan, Nigel A J, et al.
Publicado: (2022)

T cells step up after SARS-CoV-2 vaccination with B cell depletion
por: Berger, Thomas, et al.
Publicado: (2021)

Monocyte‐crosstalk drives interferon‐mediated signaling following SARS‐CoV‐2 exposure
por: Theobald, Sebastian J, et al.
Publicado: (2022)

Can ACE2 expression explain SARS‐CoV‐2 infection of the respiratory epithelia in COVID‐19?
por: Nawijn, Martijn C, et al.
Publicado: (2020)

SARS‐CoV‐2 variants as super cell fusers: cause or consequence of COVID‐19 severity?
por: Koch, Jana, et al.
Publicado: (2021)

Filtration efficiency of face masks against aerosolized surrogate SARS-CoV-2 at different social distances
por: Tang, Song, et al.
Publicado: (2022)

Human neutralizing antibodies to SARS-CoV-2: views and perspectives from Professor Linqi Zhang at Tsinghua University
por: Li, Yubin
Publicado: (2020)

An interactive viral genome evolution network analysis system enabling rapid large-scale molecular tracing of SARS-CoV-2
por: Ling, Yunchao, et al.
Publicado: (2022)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Petersen, Eskild, et al.
Publicado: (2020)

Which influenza viruses will emerge following the SARS‐CoV‐2 pandemic?
por: Laurie, Karen L., et al.
Publicado: (2021)

SARS CoV-2 seropositivity in haemodialysis patients
por: Toapanta, Nestor, et al.
Publicado: (2022)

The bullwhip effect, T-cell telomeres, and SARS-CoV-2
por: Aviv, Abraham
Publicado: (2022)

Prevention of host-to-host transmission by SARS-CoV-2 vaccines
por: Mostaghimi, Darius, et al.
Publicado: (2022)

Challenges of SARS-CoV-2 genomic surveillance in Africa
por: Adepoju, Paul
Publicado: (2021)

Views on Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease by Dai et al. (2020)
por: Odhar, Hasanain Abdulhameed
Publicado: (2020)

Detection of Anthropogenic CO(2) Emission Signatures with TanSat CO(2) and with Copernicus Sentinel-5 Precursor (S5P) NO(2) Measurements: First Results
por: Yang, Dongxu, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence in Spain
por: George, Thukalan Paulose
Publicado: (2020)

SARS-CoV-2 seroprevalence in Spain
por: Hoffmann, Christian, et al.
Publicado: (2020)

SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP()
por: Zúñiga, José, et al.
Publicado: (2021)

A data driven time-dependent transmission rate for tracking an epidemic: a case study of 2019-nCoV
por: Huang, Norden E., et al.
Publicado: (2020)

Comments on "An insertion unique to SARS-CoV-2 exhibits super antigenic character strengthened by recent mutations" by Cheng MH et al.2020
por: Chiappelli, Francesco
Publicado: (2020)

The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
por: Patel, Darshan P., et al.
Publicado: (2021)

Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2
por: Meyerowitz, Eric A, et al.
Publicado: (2021)

The role of autophagy in the pathogenesis of SARS-CoV-2 infection in different cell types
por: Samimi, Nastaran, et al.
Publicado: (2021)

Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
por: Milne, Gregory, et al.
Publicado: (2021)

Prolonged detection of SARS-CoV-2 RNA in chronic haemodialysis patients
por: Ribitsch, Werner, et al.
Publicado: (2021)

Circulation of influenza, RSV, and SARS-CoV-2: an uncertain season ahead
por: Burki, Talha Khan
Publicado: (2021)

Less attention paid to waterborne SARS-CoV-2 spreading in Beijing urban communities
por: Wang, Chunyan, et al.
Publicado: (2021)

Primary Immune Response Provides Protective Efficacy against SARS-CoV-2 Reinfection
por: Shrestha, Rupendra, et al.
Publicado: (2021)

Breath of green life: Reduction in plant day and night respiration under elevated CO(2)
por: Burgess, Alexandra J
Publicado: (2023)

Why periodontitis may be the missing link in understanding the severity of SARS-CoV-2
por: Holland, Caroline
Publicado: (2023)

First shared SARS-CoV-2 genome: GISAID vs virological.org
por: Burki, Talha
Publicado: (2023)

Colonic expression of Ace2, the SARS-CoV-2 entry receptor, is suppressed by commensal human microbiota
por: Edwinson, Adam, et al.
Publicado: (2021)

Seroprevalence and presentation of SARS-CoV-2 in pregnancy
por: Crovetto, Francesca, et al.
Publicado: (2020)

Study of seroprevalence of SARS‐CoV‐2 in Kazakhstan
por: Kulimbet, Mukhtar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vp23ch28ise8tvtm5mc3fcstg2